⌘K

Login Start Free

Home/Filings/4/0000885590-10-000053

4//SEC Filing

Fibiger Hans Christian 4

Accession 0000885590-10-000053

CIK 0000885590other

View on SEC.gov Company Profile

Filed

Oct 5, 8:00 PM ET

Accepted

Oct 6, 3:22 PM ET

Size

8.4 KB

Accession

0000885590-10-000053

Insider Transaction Report

Form 4

Period: 2010-10-04

Valeant Pharmaceuticals International, Inc.VRX

Fibiger Hans Christian

Chief Scientific Officer

Transactions

Award
Restricted Share Units
2010-10-04+52→ 14,416 total
From: 2011-11-24Exp: 2011-11-24→ Common Stock, no par value (52 underlying)
Award
Restricted Share Units
2010-10-04+187→ 51,329 total
From: 2014-08-05Exp: 2014-08-05→ Common Stock, no par value (187 underlying)

Footnotes (2)

[F1]Each Restricted Share Unit represents a contingent right to receive one share of Common Stock, no par value, of Valeant Pharmaceuticals International, Inc. (the "Common Stock").
[F2]Represents dividend equivalents accrued on Restricted Share Units as a result of a dividend paid on the Common Stock on October 4, 2010.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Valeant Pharmaceuticals International, Inc.

CIK 0000885590

Entity typeother

Related Parties

1

filerCIK 0001477122

Filing Metadata

Form type: 4
Filed: Oct 5, 8:00 PM ET
Accepted: Oct 6, 3:22 PM ET
Size: 8.4 KB

View on SEC.gov